Red Queen Therapeutics
San Diego, United States· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Total funding raised: $55M
Overview
Developing novel small molecule drugs to combat resistant and emerging infectious diseases.
Infectious Disease
Technology Platform
A small molecule discovery platform targeting novel pathogen vulnerabilities to overcome antimicrobial resistance.
Funding History
1Total raised:$55M
Venture$55M
Opportunities
Could address a critical public health crisis with support from non-dilutive funding and potential priority regulatory pathways.
Risk Factors
High risk of clinical failure and the perennial commercial challenge of achieving profitability in the antibiotic market.
Competitive Landscape
Competes in the challenging antibiotic development sector, where commercial success is difficult despite clear medical need.